Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.4M | 89 | 98.4% |
| Travel and Lodging | $21,449 | 25 | 1.5% |
| Food and Beverage | $1,437 | 17 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $869,683 | 77 | $0 (2020) |
| Agios Pharmaceuticals, Inc. | $291,781 | 35 | $0 (2019) |
| Taiho Oncology, Inc. | $216,165 | 16 | $0 (2019) |
| Valneva Austria GmbH | $9,659 | 2 | $0 (2017) |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $39,924 | 6 | Heron Therapeutics, Inc. ($39,924) |
| 2019 | $436,149 | 53 | Agios Pharmaceuticals, Inc. ($239,737) |
| 2018 | $650,730 | 50 | Heron Therapeutics, Inc. ($390,738) |
| 2017 | $260,509 | 22 | Heron Therapeutics, Inc. ($250,809) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $7,875.00 | General |
| 04/22/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 02/27/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $16,200.00 | General |
| 02/27/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Travel and Lodging | Cash or cash equivalent | $994.91 | General |
| 01/09/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $12,825.00 | General |
| 01/09/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Travel and Lodging | Cash or cash equivalent | $679.46 | General |
| 12/20/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 12/05/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Travel and Lodging | In-kind items and services | $1,294.46 | General |
| 12/05/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Food and Beverage | In-kind items and services | $77.00 | General |
| 11/14/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $12,375.00 | General |
| 10/29/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Food and Beverage | In-kind items and services | $113.29 | General |
| 10/17/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| 09/30/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $3,974.11 | General |
| 09/16/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $33,075.00 | General |
| 09/16/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| 07/24/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 07/24/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Food and Beverage | In-kind items and services | $38.67 | General |
| 07/11/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Consulting Fee | Cash or cash equivalent | $25,840.40 | General |
| 07/11/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,234.60 | General |
| 07/11/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Food and Beverage | In-kind items and services | $84.27 | General |
| 07/11/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| 06/21/2019 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| 06/20/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Consulting Fee | Cash or cash equivalent | $23,800.37 | General |
| 06/20/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,137.13 | General |
| 06/13/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Consulting Fee | Cash or cash equivalent | $20,173.65 | General |
About Dr. Gilad Gordon, MD
Dr. Gilad Gordon, MD is a Internal Medicine healthcare provider based in Boulder, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1609110006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilad Gordon, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $39,924 received in 2020. These payments were reported across 131 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1.4M).
Practice Information
- Specialty Internal Medicine
- Location Boulder, CO
- Active Since 11/26/2012
- Last Updated 11/26/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609110006
Products in Payments
- HTX-011 (Drug) $864,422
- TIBSOVO (Drug) $268,803
- TAS-102 (Drug) $8,200
- CINVANTI (Drug) $5,038
- SUSTOL (Drug) $223.04
- Lonsurf (Drug) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boulder
Richard Moseley, M.d, M.D
Internal Medicine — Payments: $16,355
Oussama Lawand, M.d, M.D
Internal Medicine — Payments: $9,331
Nicole Getzel, Do, DO
Internal Medicine — Payments: $7,154
Dr. Thomas Miller, M.d, M.D
Internal Medicine — Payments: $5,867
Jennifer Christensen, Md, MD
Internal Medicine — Payments: $1,988
Dr. Christopher Trojanovich, M.d, M.D
Internal Medicine — Payments: $1,810